Found: 28
Select item for more details and to access through your institution.
Therapeutic potential of a novel synthetic selectin blocker, OJ-R9188, in allergic dermatitis.
- Published in:
- British Journal of Pharmacology, 2001, v. 134, n. 7, p. 1498, doi. 10.1038/sj.bjp.0704397
- By:
- Publication type:
- Article
Granulomatous-lymphocytic Interstitial Lung Disease Associated with Good’s Syndrome That Responded to Immunoglobulin Therapy.
- Published in:
- Internal Medicine, 2021, v. 60, n. 19, p. 3137, doi. 10.2169/internalmedicine.6456-20
- By:
- Publication type:
- Article
Telmisartan Inhibits Cell Proliferation by Blocking Nuclear Translocation of ProHB-EGF C-Terminal Fragment in Colon Cancer Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056770
- By:
- Publication type:
- Article
Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1999, v. 65, n. 3, p. 291, doi. 10.1016/S0009-9236(99)70108-6
- By:
- Publication type:
- Article
Downhill oesophageal varices resulting from superior vena cava graft occlusion after resection of a thymoma†.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2013, v. 17, n. 3, p. 598, doi. 10.1093/icvts/ivt212
- By:
- Publication type:
- Article
Non-Linear Pharmacokinetics of Atomoxetine in Adult Japanese Patients With ADHD.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia Fluvoxamine and haloperidol interaction.
- Published in:
- Psychopharmacology, 2004, v. 171, n. 2, p. 223, doi. 10.1007/s00213-003-1567-y
- By:
- Publication type:
- Article
Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder.
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 12, p. 1213, doi. 10.1007/s00228-011-1073-9
- By:
- Publication type:
- Article
Effect of dose timing in relation to food intake on systemic exposure to blonanserin.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 9, p. 899, doi. 10.1007/s00228-010-0834-1
- By:
- Publication type:
- Article
Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder.
- Published in:
- European Journal of Clinical Pharmacology, 2009, v. 65, n. 7, p. 685, doi. 10.1007/s00228-009-0633-8
- By:
- Publication type:
- Article
Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2007, v. 63, n. 1, p. 51, doi. 10.1007/s00228-006-0217-9
- By:
- Publication type:
- Article
Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 58, n. 12, p. 829, doi. 10.1007/s00228-003-0563-9
- By:
- Publication type:
- Article
Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 4, p. 507, doi. 10.1007/s00280-006-0292-8
- By:
- Publication type:
- Article
Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 60, n. 2, p. 172, doi. 10.1111/j.1365-2125.2005.02380.x
- By:
- Publication type:
- Article
Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes.
- Published in:
- British Journal of Clinical Pharmacology, 2004, v. 57, n. 4, p. 487, doi. 10.1111/j.1365-2125.2003.02047.x
- By:
- Publication type:
- Article
The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: A preliminary study in a psychiatric population.
- Published in:
- Psychiatry & Clinical Neurosciences, 1999, v. 53, n. 5, p. 593, doi. 10.1046/j.1440-1819.1999.00611.x
- By:
- Publication type:
- Article
Lack of Correlation between the Steady-State Plasma Concentrations of Haloperidol and Risperidone.
- Published in:
- Journal of Clinical Pharmacology, 2002, v. 42, n. 10, p. 1083, doi. 10.1177/009127002237989
- By:
- Publication type:
- Article
Stapling of an endobronchial suction tube with the bronchus during robot-assisted right lower lobectomy: a case report.
- Published in:
- Surgical Case Reports, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40792-021-01278-5
- By:
- Publication type:
- Article
Novel Hydroquinone as a Matrix Metallo-proteinase Inhibitor from the Mushroom, Piptoporus betulinus.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2002, v. 66, n. 12, p. 2748, doi. 10.1271/bbb.66.2748
- By:
- Publication type:
- Article
QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 1, p. 39, doi. 10.1002/hup.1258
- By:
- Publication type:
- Article
Effect of the cytochrome P450 2D6*10 allele on risperidone metabolism in Japanese psychiatric patients.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 1, p. 43, doi. 10.1002/hup.1260
- By:
- Publication type:
- Article
Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 8, p. 602, doi. 10.1002/hup.1252
- By:
- Publication type:
- Article
Association between plasma paroxetine concentration and changes in plasma brain-derived neurotrophic factor levels in patients with major depressive disorder.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 3, p. 194, doi. 10.1002/hup.1192
- By:
- Publication type:
- Article
Prolactin fluctuation over the course of a day during treatments with three atypical antipsychotics in schizophrenic patients.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2010, v. 25, n. 3, p. 236, doi. 10.1002/hup.1110
- By:
- Publication type:
- Article
CYP2D6*10 polymorphism and the enantioselective O‐desmethylation of S‐(+)‐ and R‐(‐)‐venlafaxine in Japanese psychiatric patients.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 128, n. 5, p. 677, doi. 10.1111/bcpt.13560
- By:
- Publication type:
- Article
Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients.
- Published in:
- Psychopharmacology, 1999, v. 145, n. 2, p. 189, doi. 10.1007/s002130051048
- By:
- Publication type:
- Article
Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder.
- Published in:
- Neuropsychiatric Disease & Treatment, 2014, v. 10, p. 1793, doi. 10.2147/NDT.S68670
- By:
- Publication type:
- Article
CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype–phenotype association study design in translational pharmacogenetics.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 7, p. 908, doi. 10.1177/0269881110370504
- By:
- Publication type:
- Article